Europe shares snap two-day slide; Novo Nordisk rallies
* FTSEurofirst 300 up 0.6 pct after losing 1.9 pct in 2 days
* Euro zone shares recover as euro falls back
* Novo Nordisk up 8.6 pct after deciding to submit drug data
By Blaise Robinson
PARIS, March 27 (Reuters) - European stocks rose in early trade on Friday, halting a sharp two-day retreat as a renewed fall in the euro helped boost exporters' shares.
Denmark's Novo Nordisk featured among the top gainers, up 13 percent after the pharmaceutical firm said it would submit interim data from a clinical trial of its crucial new insulin drug Tresiba to U.S. regulators within the next month.
At 0827 GMT, the FTSEurofirst 300 index of top European shares was up 0.6 percent at 1,583.03 points.
European stocks tumbled in the past two sessions, with the FTSEurofirst 300 losing 1.9 percent as a rebounding euro currency prompted investors to cash in recent sharp gains.
The euro fell back on Friday, trading at $1.0811, well below Thursday's intraday high of $1.10525. European shares have strongly rallied in the past six months as investors bet a sharp drop in the currency would boost the region's economy and lift corporate results. Continuación...